• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Debiopharm International SA - Articles and news items

debio 1143

EMA grants Orphan Drug Designation for Debio 1143

Industry news / 8 December 2015 / Victoria White

Debio1143 is an oral, small molecule inhibitor of IAPs with a dual pro-apoptotic and immunomodulatory mode of action developed as a potent chemo/radiosensitiser in ovarian cancer…

debiopharm-central-precocious-puberty

Debiopharm announces positive Phase III results for triptorelin 6-month formulation in the management of central precocious puberty

Industry news / 19 May 2015 / Victoria White

Debiopharm has announced the completion of a Phase III study with triptorelin 6-month formulation in 44 patients with central precocious puberty…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +